<DOC>
	<DOCNO>NCT02576119</DOCNO>
	<brief_summary>The purpose study determine effect multiple dose BMS-955176 QT interval correct Fridericia 's method ( QTcF ) healthy subject .</brief_summary>
	<brief_title>A Study Determine Effect Multiple Doses BMS-955176 Electrocardiograph Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>1 . Written Informed Consent 2 . Healthy subject determine clinically significant deviation normal medical history , physical examination finding , 12lead ECG measurement , physical measurement , clinical laboratory test result 3 . Body mass index ( BMI ) 18.0 kg/m2 32.0 kg/m2 , inclusive , screen Day 1 . BMI = weight ( kg ) / [ height ( ) ] 2 4 . Women must negative serum pregnancy test , must breastfeed , woman child bear potential ( WOCBP ) must agree follow instruction method ( ) contraception duration treatment BMS955176 addition posttreatment completion period 5 . Males sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment BMS955176 addition posttreatment completion period 1 . Any significant acute chronic medical illness 2 . Any GI disease surgery affect absorption study drug 3 . A personal history clinically relevant cardiac disease , long QT syndrome , symptomatic asymptomatic arrhythmia , presyncope syncopal episode , additional risk factor torsades de pointes ( eg , heart failure ) 4 . Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population 5 . History allergy moxifloxacin , HIV maturation inhibitor , related compound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>